INBIFO Institut fir biologische Forschung GmbH - Kéin PRIORITY

 

Report P 0500/3237 970/83 Page 69
= 1200
s 4 : VIRGO-CA
2 © + VIRGO-CC
6 Oo: 1R4F
i So see : without S9
| gz 1000 ——— : with $9
Q
oe a
: td
| @
Ee
| = 2 800

  

 

600
. 400
| - 200
0
8 T To]
pod 8 0.0 02 04 06 08 10

TPM DOSE (mg/plate)

Figure 3 Mutagenicity of TPM in Strain TA100

 

; ‘| Remarks; mean + SE, N = 12 plates
i data see Tables 5, 9, 13, 22, 23, 30, and 31

PELLLLESOZ